Prohibition Partners
Home / Reports & Data / UK Medical Cannabis Market Update 2026
ReportUnited Kingdom

UK Medical Cannabis Market Update 2026

Prohibition Partners' UK Medical Cannabis Market Update 2026 is the definitive read on one of Europe's fastest-moving cannabis markets.

  • Analyst-written market analysis
  • PDF
  • Published 2026

Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.

Trusted by teams at

DIAGEOKPMGBarclaysNovartisBloomberg

About this edition

Prohibition Partners' UK Medical Cannabis Market Update 2026 is the definitive read on one of Europe's fastest-moving cannabis markets. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.

PDF

delivery format

2026

published

Inside this edition

Contents12
  • Executive Summary
  • Market Overview
  • Imports
  • Product and Pricing Analysis
  • Market Size and Growth Trajectory
  • Strategic Implications
  • Acronyms and Abbreviations
  • Plus a 28-sheet Excel data pack: imports, prices, volumes, market-sizing scenarios, patient sizing, clinics and product-level breakdowns
  • £302M–£389M estimated UK medical cannabis market size (2026)
  • 140,000+ estimated patients (2026)
  • 30,061 kg of cannabis-based medicinal products imported (2025)
  • 800+ medical cannabis products available (March 2026)

Who it’s for

Investors & analysts

Defensible sizing and forecasts to underwrite the thesis.

Corporate strategy & FMCG

Opportunity sizing and entry routes across key markets.

More from the library

All research